LIDORESTAT Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treat ment of diabetic complications, including neuropathy, retinopathy, cataracts, nephropathy (selective aldose reductase inhibitor).

LIDORESTAT Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LIDORESTAT Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49979	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32466	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58
Cochemical Co. Ltd.	+86-029-86115547 +86-17791676824	sales@cochemical.com	China	3952	58
Nanjing Moldeep Biochemical Co., Ltd.	+86-25-58282389 +8618913958656	inquiries@moldeep.com	China	20000	58
Cochemical Ltd.	029-86115547 17791676824	sales@cochemical.com	China	3014	58
Shanghai YuanYe Biotechnology Co., Ltd.	13636370518	shyysw007@163.com	China	89686	60
Cochemical Ltd.	029-86115547 17791676824	sales@cochemical.com	China	6642	58
Wuxi AppTec	022-59987777 13552403979	jia_guoqiang@wuxiapptec.com	China	22345	58
Aikon International Limited	025-58859352 13913916777	dt3@aikonchem.com	China	15491	58

---

• LIDORESTAT
• 1H-Indole-1-aceticacid, 3-[(4,5,7-trifluoro-2-benzothiazolyl)methyl]-
• [3-(4,5,7-Trifluorobenzothiazol-2-ylmethyl)indol-1-yl]acetic acid
• 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid
• 2-(3-((4,5,7-TRIFLUOROBENZO[D]THIAZOL-2-YL)METHYL)-1H-INDOL-1-YL)ACETIC ACID
• LIDORESTATUM
• IDD-676
• (VOI)LIDORESTAT
• Lidorestat (IDD-676)
• 245116-90-9